mirajet
A New Realm in Needleless Drug Delivery

None can deny that the desire to look younger has reigned over our minds since ages. However, with time, the unavoidable effects of aging begin to take its toll on the skin—muscle tone tends to deteriorate, and facial skin begins to wrinkle and lose volume, which eventually leads to an unaesthetic appearance. Sometimes, even with a strict diet regimen, daily exercise, and a good eight hours of sleep a day, people notice the appearance of fine wrinkles on forehead and crow’s feet around eyes that look all computer-screen dry. While many opt for facelifts (wrinkles, skin improvement; elasticity, tone) and other invasive procedures, these come with a set of challenges and risks, including anesthesia risks, infection, numbness, or other changes in skin sensation. The simple and clear alternative to such treatments would be something non-invasive, non-surgical with all the benefits of an anti-aging procedure, minus the possible side-effects.

What if we could spray small streams of drugs directly into the skin without using any needle or thermal damage? Drug injection is undoubtedly more effective, and the results are visible, more effective, and quick. With this concept as the cornerstone, Korea-based JSK Biomed (mirajet) is fundamentally transforming the anti-aging market with its one-of-a-kind Trans-Dermal Drug Delivery System (TDDS.) mirajet’s CEO, Jin-Woo Jeon, explains, “Longevity of 100 years old has become common due to the extension of human lifespan and the development of medical science. With this, the demand for anti-aging treatments has exploded. But, the effect of passive anti-aging such as cosmetics is insignificant. This is where direct drug injection is making a world of difference with its near immediate and long-lasting results.” mirajet is the world’s first innovative drug delivery system that introduces laser pressure-based micro-jet technology. Transforming light energy into pressure and turning drugs into micro-jet, mirajet sprays a small amount of drug into the dermis.

A Closer Look at mirajet’s TDDS

Targeted to the dermis layer, mirajet can penetrate up to around 2mm into the skin, which resolves the problem of limiting the types of drugs available. With mirajet, the dosage amount can be controlled—even 0.3ul/shot can be controlled—which significantly impacts the result. When a small amount of the drug is spread evenly, the effect is maximized.

This allows a doctor to predict the result and increased reproducibility of result. mirajet also enables micro-jet shots—40shots/sec or 2,400/min—making the treatment quick. There are no risks associated with thermal damage or use of needles, and the volume of drugs, such as hyaluronic acid, Botulinum toxin, Vitamins, Glucose, PDRN, and more, injected to the dermis can be optimized. What makes mirajet an even more lucrative anti-aging solution is that it renders fast results with minimal downtime as well as fast recovery. Jin-Woo Jeon adds, “Especially in the pore, scar, and stretch mark field, we have received great feedback. The mechanism can be divided into two aspects—the drug itself effect and when micro-jet makes channels on the skin and the drug strongly spreads under the skin, it results in wound healing.”

• ‘Penetration depth control, Precise Dosage Amount control, Fast injection are what the existing methods (Needle, air-jet system) cannot provide’ Given that the global facial cosmetic medical market is projected to reach approximately $22 Billion in the year 2022, the need for innovative devices is on the rise simultaneously. mirajet is perfectly poised to lead the global market with its safe and effective technology so that more people can easily access anti-aging treatment. “The core value of future anti-aging treatments is to be able to always produce predictable and consistent results, and aim for safe, fast, and effective treatments. mirajet is constantly researching and developing products and services that meet these market requirements,” says Jin-Woo Jeon. In terms of technology, mirajet has introduced a novel idea that is far superior and different from that of existing competitors. With a new concept of technology and product using laser, it solves the problems related to existing products (pain, difficulty in controlling penetration depth and penetration amount, side effects caused by this, long downtime, to name a few.)

mirajet enables doctors to deliver more professional treatment through the device, which they find comfortable to use for their familiarity with the laser method. From the patient’s point of view, it allows them to return to daily life safely and quickly with a more effective and damage(downtime)- free technology. Jin-Woo Jeon recalls, “When the first mass-produced prototype was demonstrated at a dermatology clinic, the customer or doctor, was not really impressed because it did not show the expected performance, such as low reproducibility.” However, as a result of refining all of the company’s capabilities in a month and focusing on product improvement, the reproducibility of the product was greatly increased. This led to piquing the interest of customers in using the product again.

Rewriting the Tenets of Anti-Aging

Jin-Woo Jeon believes that the advantage of preoccupying the differentiated needle-free drug delivery technology in the market and steadily accumulating clinical data on it can increase the entry barrier for latecomers and help mirajet gain a competitive advantage in the market.
With a strong value proposition in place, mirajet is one of those companies that occupy the top position in the medical device market with their own technology, creating a profound impact in each field. mirajet’s unique and innovative product line makes it a step ahead of numerous companies that replicate ideas crudely, without originality, and fail to keep their reputation and brand intact.

• Internally & externally (abroad) we have achieved 10 patents (registered) and other 21 patents are on progress.

• Vision: making ‘mirajet’ as the top and standard brand in DDS (Drug Delivery System) field.

mirajet is the first original technology company and continues to maintain its position by leading the needle-free drug delivery devices market. “Since we are a manufacturer and we have the original technology, it is easy to provide high-quality training and support documents related to certificate to our partners. We have already acquired the Korean (MFDS) and European (CE) medical certificate, and the U.S. certificate in progress,” mentions Jin-Woo Jeon. “In addition, for a startup company, it requires a lot of cost and time related to product mass production and certification; so, financing is also an issue. However, we have managed well with investments of the investors and doctors. Our investment attraction success is significantly high ($3.4M)” he adds.

The core technology and value of mirajet is not only applicable in the field of cosmetic medicine, but also in different areas such as vaccine, insulin delivery, and eye, human organ (heart, liver, lung, etc.) drug delivery. The potential value of mirajet for drug application in livestock and companion animals is very high as well. In the future, mirajet envisions expanding its market reach for overall drug delivery, such as insulin and vaccines. The company is also looking for partners to implement a G2M strategy together.